Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
MEK inhibitor trametinib shows potential in pediatric JMML treatment

MEK inhibitor trametinib shows potential in pediatric JMML treatment

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

New treatment approach improves recurrence-free survival in early breast cancer patients

New treatment approach improves recurrence-free survival in early breast cancer patients

Study unlocks the mystery of neonatal neutropenia in newborns

Study unlocks the mystery of neonatal neutropenia in newborns

Small-molecule A485 mobilizes white blood cells on demand

Small-molecule A485 mobilizes white blood cells on demand

New device rapidly provides white blood cell count with a single drop of blood

New device rapidly provides white blood cell count with a single drop of blood

Researchers find powerful combo weapon against aggressive lymphoma

Researchers find powerful combo weapon against aggressive lymphoma

New combination treatment offers hope for older patients with mantle cell lymphoma

New combination treatment offers hope for older patients with mantle cell lymphoma

New drug combination doubles effectiveness in shrinking enlarged spleens in myelofibrosis patients

New drug combination doubles effectiveness in shrinking enlarged spleens in myelofibrosis patients

MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer

MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer

Resistant potato starch usage found to be feasible and safe for hematopoietic stem cell transplantation patients

Resistant potato starch usage found to be feasible and safe for hematopoietic stem cell transplantation patients

Stem cell transplant offers hope for patients with multiple sclerosis

Stem cell transplant offers hope for patients with multiple sclerosis

Stem cell transplant offers hope for MS patients, study finds

Stem cell transplant offers hope for MS patients, study finds

New oral agent shows promise in treatment of relapsed multiple myeloma

New oral agent shows promise in treatment of relapsed multiple myeloma

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

Can a low-bacterial diet improve outcomes for neutropenic cancer patients?

Can a low-bacterial diet improve outcomes for neutropenic cancer patients?

What effect does honey have on human health?

What effect does honey have on human health?

Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients

Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.